US awards Moderna $590 million for bird flu vaccine development
(Reuters) -The U.S. government has awarded Moderna (NASDAQ:MRNA) $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans. This is in addition to $176
